Does TISLELIZUMAB Cause Myelosuppression? 2,142 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,142 reports of Myelosuppression have been filed in association with TISLELIZUMAB (TEVIMBRA). This represents 42.9% of all adverse event reports for TISLELIZUMAB.
2,142
Reports of Myelosuppression with TISLELIZUMAB
42.9%
of all TISLELIZUMAB reports
5
Deaths
1,052
Hospitalizations
How Dangerous Is Myelosuppression From TISLELIZUMAB?
Of the 2,142 reports, 5 (0.2%) resulted in death, 1,052 (49.1%) required hospitalization, and 91 (4.2%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TISLELIZUMAB. However, 2,142 reports have been filed with the FAERS database.
What Other Side Effects Does TISLELIZUMAB Cause?
White blood cell count decreased (327)
Neutrophil count decreased (277)
Hepatic function abnormal (221)
Pruritus (213)
Rash (208)
Platelet count decreased (183)
Pyrexia (175)
Nausea (165)
Diarrhoea (145)
Liver injury (139)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
METHOTREXATE (1,523)
Which TISLELIZUMAB Alternatives Have Lower Myelosuppression Risk?
TISLELIZUMAB vs TISOTUMAB VEDOTIN
TISLELIZUMAB vs TISOTUMAB VEDOTIN-TFTV
TISLELIZUMAB vs TITANIUM DIOXIDE\ZINC
TISLELIZUMAB vs TIVICAY
TISLELIZUMAB vs TIVOZANIB